Subscribe to Search results

The minutes of the ACVSB meeting recorded concern that there would be "problems of counselling donors in view of the state of knowledge about the significance of a positive reaction to the test."

Published on:

Professor Cash, SNBTS, wrote to Dr Gunson, NBTS, seeking his view on HCV lookback. He wrote: "You will have noted that our team have indicated the need for a policy statement and in their view 'look-back' should be attempted."

Published on:

Professor Cash provided a letter to Dr Gunson about the impact of the Gulf conflict relating to HCV Lookback.

Published on:

Dr Harrison held the view that a lookback study was "too late".

Published on:

Dr Contreras described how there was insufficient time to obtain ethical approval at each hospital for a lookback study.

Published on:

In a meeting on national study on surrogate NANBH markers in blood donors, it was agreed there would be no attempt to follow up on the recipients of surrogate marker positive donations.

Published on:

Dr Geoffrey Dusheiko advocated for obtaining a research grant "for [the] potentially clinically beneficial undertaking" of considering the value of treatment by interferon and ribavirin.

Published on:

The SACTTI meeting found that a "major limiting factor to completion of the look-back" was the unavailability of medical records.

Published on:

Medical officers of the Ministry of Health published a memorandum in "The Lancet" about incidences of jaundice.

Published on:

A letter from Dr Mitchell to Professor Cash discussed whether the BTS should have a lookback policy so as to identify donors who may have transmitted non-A non-B Hepatitis.

Published on:

Professor Cash wrote to Dr Gunson to see if he would establish a UK BTS and lookback study as soon as possible.

Published on:

Dr Gunson spoke to Professor Allain who agreed to provide a protocol for a prospective lookback study.

Published on:

Dr Elizabeth Love described that there was a requirement for "clear, written guidance" in relation to being able to offer screening tests at transfusion centres.

Published on:

A fax message from Dr David Hutton to Dr Robinson detailed the figures from the Welsh Blood Service.

Published on:

From late 1994 onwards the discussion about whether to have a national Hepatitis C lookback began to be framed in terms of an existence of a duty of care towards donor
and recipients, as was discussed in the draft report from the Advisory Committee on the Microbiological Safety of Blood and Tissue Subcommittee.

Published on:

Members of the MSBT subcommittee were asked whether they would like to support a lookback programme and consideration should be given to the ethical and legal implications of contacting recipients of Hepatitis C blood. All members voted in favour of a UK-wide approach.

Published on:

A press release from the Department of Health recorded that an ad hoc working party of experts was to be brought together to draw up guidance on the procedure for undertaking lookback and for counselling those identified as being at risk, as well as guidance on the treatment options available.

Published on:

Dr Williamson of the East Anglian Blood Transfusion Centre noted that it was much more difficult to obtain the cause of death of patients for the HCV lookback scheme and noted that it was a labour and time intensive process.

Published on:

Dr Dillon was instructed to produce draft material on counselling based on existing material used by the SNBTS.

Published on:

The announcement of an HCV lookback scheme was seen as rather sudden and a memo from Sue Knowles to Dr Lorna Williamson asked for further information on the HCV lookback scheme; "If anyone has gleaned any more than I have, please do share it!"

Published on: